| Literature DB >> 23259934 |
Nadia M Noor Abdulhadi1, Mohammed Ali Al-Shafaee, Rolf Wahlström, Katarina Hjelm.
Abstract
AIM: This study aimed at exploring the experiences of primary health-care providers of their encounters with patients with type 2 diabetes, and their preferences and suggestions for future improvement of diabetes care.Entities:
Mesh:
Year: 2012 PMID: 23259934 PMCID: PMC3682753 DOI: 10.1017/S146342361200062X
Source DB: PubMed Journal: Prim Health Care Res Dev ISSN: 1463-4236 Impact factor: 1.458
Demographic characteristics of the participants
| Variable | Doctors ( | Nurses ( |
|---|---|---|
| Sex | ||
| Females | 8 | 7 |
| Males | 11 | 0 |
| Age: median (range) | 40 (29–55) years | 30 (25–40) years |
| Arabic speaking | 11 | 5 |
| Non-Arabic speaking | 8 | 2 |
| Thank you for being willing to take part in this interview. I would like first to assure you that no records of this interview would be kept with your name on them. |
| 1 – Could you please start by describing an adult patient with type 2 diabetes you have seen recently? |
| Probes: |
| • Please tell me what happened when this patient came to you? |
| • Could you describe what you discussed when this patient consulted you? |
| • What did you tell this patient about his/her health condition? |
| • Did you experience any difficulties in the communication and interaction with this patient? |
| 2 – In general, do you experience difficulties in communication with patients with type 2 diabetes? If difficulties are present, the following two questions are: |
| 2a – Will you please explain the types of difficulties? |
| 2b – How do you deal with such difficulties? |
| 3 – Are you usually able to see solutions to problems and difficulties when dealing with patients with type 2 diabetes? |
| 4 – What are your suggestions to achieve optimum interaction with patients with type 2 diabetes in the future? |
| Meaning unit | Code/codes | Sub-category | Category |
|---|---|---|---|
| Yes, mainly some patients being on maximum dosage of tablets, but the glycaemic control is not good. I added glitazone to her old medication but she did not use it. I want to start insulin but there is a reluctance to use the insulin. It seems to be there are some beliefs among patients that if they are on insulin that is the end of it, it's like a terminal case so they don't accept that. We reinforce changes in lifestyle, and just keep on waiting and hoping. | • Maximum dose anti-diabetes tablets | Poor patient adherence to medicine | Patient factors |
| • Poor glycaemic control | |||
| • Reluctance to add new medicine | |||
| • Reluctance to start insulin | |||
| • Beliefs about insulin | |||
| I and the nurse discussed with her many times about the use and benefit of prescribing anti-diabetes medicines and prevention of complications. We do our best but the patients do not listen and do not understand. I am fed up and also I threatened her in the last visit that I will not prescribe any medicine again since she is not using them; then the patient was shocked and promised to be compliant. | • Explanation of benefit of using anti-diabetes medicine | Doctors’ and nurses’ frustration | Factors related to health-care providers |
| • Provision of care and health education to the patients | |||
| • Doctor is fed up | |||
| • Threatening the patients |